|
CYB5R4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.13619999999537E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.223100E-04 |
| Normal-vs-Stage2 |
6.22059999955127E-07 |
| Normal-vs-Stage3 |
3.941200E-03 |
| Normal-vs-Stage4 |
4.776300E-04 |
| Stage1-vs-Stage2 |
4.798900E-03 |
| Stage1-vs-Stage3 |
9.038200E-01 |
| Stage1-vs-Stage4 |
2.560200E-01 |
| Stage2-vs-Stage3 |
1.211920E-02 |
| Stage2-vs-Stage4 |
1.531600E-01 |
| Stage3-vs-Stage4 |
3.938400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.339440E-03 |
| Normal-vs-AfricanAmerican |
1.044320E-02 |
| Normal-vs-Asian |
2.158500E-04 |
| Caucasian-vs-AfricanAmerican |
5.870800E-01 |
| Caucasian-vs-Asian |
1.427430E-01 |
| AfricanAmerican-vs-Asian |
7.346200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.602800E-04 |
| Normal-vs-Female |
6.04519999999331E-05 |
| Male-vs-Female |
9.786200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.460700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.55169999999094E-05 |
| Normal-vs-Age(61-80Yrs) |
3.355700E-04 |
| Normal-vs-Age(81-100Yrs) |
7.244200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.067800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.240200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.121760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.610800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.520300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.400500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.782600E-01 |
| Classical-VS-Follicular |
4.38750002995647E-09 |
| Classical-VS-Other |
1.777450E-01 |
| Classical-VS-Normal |
2.263400E-03 |
| Tall-VS-Follicular |
8.387500E-04 |
| Tall-VS-Other |
1.319770E-01 |
| Tall-VS-Normal |
4.498000E-01 |
| Follicular-VS-Other |
6.270200E-01 |
| Follicular-VS-Normal |
8.15409961774094E-11 |
| Other-VS-Normal |
1.603970E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.0410999995436E-07 |
| Normal-vs-N1 |
6.576000E-04 |
| N0-vs-N1 |
5.194800E-01 |
|
|
